These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 31451517)
1. A Protective Effect of PPARα in Endothelial Progenitor Cells Through Regulating Metabolism. Shao Y; Chen J; Dong LJ; He X; Cheng R; Zhou K; Liu J; Qiu F; Li XR; Ma JX Diabetes; 2019 Nov; 68(11):2131-2142. PubMed ID: 31451517 [TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptor α protects capillary pericytes in the retina. Ding L; Cheng R; Hu Y; Takahashi Y; Jenkins AJ; Keech AC; Humphries KM; Gu X; Elliott MH; Xia X; Ma JX Am J Pathol; 2014 Oct; 184(10):2709-20. PubMed ID: 25108226 [TBL] [Abstract][Full Text] [Related]
3. Pathogenic Role of Chen Q; Qiu F; Zhou K; Matlock HG; Takahashi Y; Rajala RVS; Yang Y; Moran E; Ma JX Diabetes; 2017 Jun; 66(6):1671-1682. PubMed ID: 28270521 [TBL] [Abstract][Full Text] [Related]
4. Pathogenic role of diabetes-induced PPAR-α down-regulation in microvascular dysfunction. Hu Y; Chen Y; Ding L; He X; Takahashi Y; Gao Y; Shen W; Cheng R; Chen Q; Qi X; Boulton ME; Ma JX Proc Natl Acad Sci U S A; 2013 Sep; 110(38):15401-6. PubMed ID: 24003152 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic effects of PPARα agonists on diabetic retinopathy in type 1 diabetes models. Chen Y; Hu Y; Lin M; Jenkins AJ; Keech AC; Mott R; Lyons TJ; Ma JX Diabetes; 2013 Jan; 62(1):261-72. PubMed ID: 23043158 [TBL] [Abstract][Full Text] [Related]
6. Regulation of Monocyte Activation by PPARα Through Interaction With the cGAS-STING Pathway. Dong L; Cheng R; Ma X; Liang W; Hong Y; Li H; Zhou K; Du Y; Takahashi Y; Zhang X; Li XR; Ma JX Diabetes; 2023 Jul; 72(7):958-972. PubMed ID: 37058417 [TBL] [Abstract][Full Text] [Related]
7. Pathogenic Role of PPARα Downregulation in Corneal Nerve Degeneration and Impaired Corneal Sensitivity in Diabetes. Matlock HG; Qiu F; Malechka V; Zhou K; Cheng R; Benyajati S; Whelchel A; Karamichos D; Ma JX Diabetes; 2020 Jun; 69(6):1279-1291. PubMed ID: 32213513 [TBL] [Abstract][Full Text] [Related]
8. PPARα Agonist Stimulated Angiogenesis by Improving Endothelial Precursor Cell Function Via a NLRP3 Inflammasome Pathway. Deng Y; Han X; Yao Z; Sun Y; Yu J; Cai J; Ren G; Jiang G; Han F Cell Physiol Biochem; 2017; 42(6):2255-2266. PubMed ID: 28817808 [TBL] [Abstract][Full Text] [Related]
9. Neuroprotective effects of PPARα in retinopathy of type 1 diabetes. Pearsall EA; Cheng R; Matsuzaki S; Zhou K; Ding L; Ahn B; Kinter M; Humphries KM; Quiambao AB; Farjo RA; Ma JX PLoS One; 2019; 14(2):e0208399. PubMed ID: 30716067 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic Effects of a Novel Agonist of Peroxisome Proliferator-Activated Receptor Alpha for the Treatment of Diabetic Retinopathy. Deng G; Moran EP; Cheng R; Matlock G; Zhou K; Moran D; Chen D; Yu Q; Ma JX Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5030-5042. PubMed ID: 28979999 [TBL] [Abstract][Full Text] [Related]
11. The dual PPARα/γ agonist aleglitazar increases the number and function of endothelial progenitor cells: implications for vascular function and atherogenesis. Werner CM; Schirmer SH; Gensch C; Pavlickova V; Pöss J; Wright MB; Böhm M; Laufs U Br J Pharmacol; 2014 May; 171(10):2685-703. PubMed ID: 24467636 [TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor-α (PPARα) regulates wound healing and mitochondrial metabolism in the cornea. Liang W; Huang L; Whelchel A; Yuan T; Ma X; Cheng R; Takahashi Y; Karamichos D; Ma JX Proc Natl Acad Sci U S A; 2023 Mar; 120(13):e2217576120. PubMed ID: 36943878 [TBL] [Abstract][Full Text] [Related]
13. PPARα regulates mobilization and homing of endothelial progenitor cells through the HIF-1α/SDF-1 pathway. Wang Z; Moran E; Ding L; Cheng R; Xu X; Ma JX Invest Ophthalmol Vis Sci; 2014 May; 55(6):3820-32. PubMed ID: 24845641 [TBL] [Abstract][Full Text] [Related]
14. CEPT1-Mediated Phospholipogenesis Regulates Endothelial Cell Function and Ischemia-Induced Angiogenesis Through PPARα. Zayed MA; Jin X; Yang C; Belaygorod L; Engel C; Desai K; Harroun N; Saffaf O; Patterson BW; Hsu FF; Semenkovich CF Diabetes; 2021 Feb; 70(2):549-561. PubMed ID: 33214136 [TBL] [Abstract][Full Text] [Related]
15. Fenofibrate-Loaded Biodegradable Nanoparticles for the Treatment of Experimental Diabetic Retinopathy and Neovascular Age-Related Macular Degeneration. Qiu F; Meng T; Chen Q; Zhou K; Shao Y; Matlock G; Ma X; Wu W; Du Y; Wang X; Deng G; Ma JX; Xu Q Mol Pharm; 2019 May; 16(5):1958-1970. PubMed ID: 30912953 [TBL] [Abstract][Full Text] [Related]
16. PPARalpha agonist fenofibrate improves diabetic nephropathy in db/db mice. Park CW; Zhang Y; Zhang X; Wu J; Chen L; Cha DR; Su D; Hwang MT; Fan X; Davis L; Striker G; Zheng F; Breyer M; Guan Y Kidney Int; 2006 May; 69(9):1511-7. PubMed ID: 16672921 [TBL] [Abstract][Full Text] [Related]
17. The Protective Role of Microglial PPARα in Diabetic Retinal Neurodegeneration and Neurovascular Dysfunction. Yuan T; Dong L; Pearsall EA; Zhou K; Cheng R; Ma JX Cells; 2022 Dec; 11(23):. PubMed ID: 36497130 [TBL] [Abstract][Full Text] [Related]
18. Accelerated diabetic nephropathy in mice lacking the peroxisome proliferator-activated receptor alpha. Park CW; Kim HW; Ko SH; Chung HW; Lim SW; Yang CW; Chang YS; Sugawara A; Guan Y; Breyer MD Diabetes; 2006 Apr; 55(4):885-93. PubMed ID: 16567507 [TBL] [Abstract][Full Text] [Related]